Larimar Therapeutics, Inc. (LRMR)
NASDAQ
Market Cap
$207.37M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
15 of 951
Rank in Industry
12 of 544
Largest Insider Buys in Sector
LRMR Stock Price History Chart
LRMR Stock Performance
About Larimar Therapeutics, Inc.
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.
Insider Activity of Larimar Therapeutics, Inc.
Over the last 12 months, insiders at Larimar Therapeutics, Inc. have bought $38.02M and sold $0 worth of Larimar Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Larimar Therapeutics, Inc. have bought $20.2M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Flynn James E (* Director by Deputization) — $1.42B. Hamilton Thomas Edward (director) — $999,996. THOMAS FRANK E (director) — $22,000.
The last purchase of 4,290,617 shares for transaction amount of $37.5M was made by Flynn James E (* Director by Deputization) on 2024‑02‑16.
List of Insider Buy and Sell Transactions, Larimar Therapeutics, Inc.
| 2024-02-16 | * Director by Deputization | 4.29M 6.6831% | $8.74 | $37.5M | -41.31% | |||
| 2024-02-16 | director | 57,208 0.0891% | $8.74 | $499,998 | -41.31% | |||
| 2024-02-14 | director | 2,000 0.0064% | $11.00 | $22,000 | -37.00% | |||
| 2023-12-07 | Chief Development Officer | 5,000 0.0119% | $3.73 | $18,662 | +103.31% | |||
| 2023-05-17 | President and CEO | 5,000 0.0114% | $3.71 | $18,525 | +8.67% | |||
| 2023-05-17 | Chief Financial Officer | 5,000 0.0115% | $3.73 | $18,632 | +8.67% | |||
| 2023-05-17 | director | 2,750 0.0063% | $3.73 | $10,258 | +8.67% | |||
| 2022-09-16 | 11.11M 49.2054% | $3.15 | $35M | +21.88% | ||||
| 2022-09-16 | director | 317,460 1.4059% | $3.15 | $999,999 | +21.88% | |||
| 2022-09-16 | President and CEO | 31,746 0.1406% | $3.15 | $100,000 | +21.88% | |||
| 2022-09-16 | Chief Financial Officer | 31,746 0.1406% | $3.15 | $100,000 | +21.88% | |||
| 2021-06-30 | 685,710 3.341% | $8.75 | $6M | -2.39% | ||||
| 2021-06-30 | director | 56,710 0.2763% | $8.75 | $496,213 | -2.39% | |||
| 2018-06-28 | Sale | See Remarks | 32,000 0.1034% | $10.00 | $320,000 | -47.50% | ||
| 2018-03-07 | Sale | See Remarks | 5,000 0.0194% | $10.00 | $50,000 | -8.25% | ||
| 2017-10-13 | director | 20,000 0.0343% | $1.95 | $38,988 | +75.12% | |||
| 2017-07-11 | Chief Medical Officer | 20,000 0.037% | $1.70 | $33,900 | +63.77% | |||
| 2017-05-11 | Chief Medical Officer | 19,600 0.0729% | $4.40 | $86,240 | -12.41% | |||
| 2017-05-10 | Chief Medical Officer | 400 0.0014% | $4.40 | $1,760 | -15.92% | |||
| 2016-12-19 | director | 20,000 0.0742% | $3.23 | $64,580 | +16.61% |
Insider Historical Profitability
9.25%
| Flynn James E | * Director by Deputization | 6151406 9.6407% | $3.25 | 7 | 1 | <0.0001% |
| Hamilton Thomas Edward | director | 564798 0.8852% | $3.25 | 3 | 0 | +21.88% |
| THOMAS FRANK E | director | 2000 0.0031% | $3.25 | 1 | 0 | |
| BEN-MAIMON CAROLE | President and CEO | 266829 0.4182% | $3.25 | 2 | 0 | +15.27% |
| STARR KEVIN P | director | 210371 0.3297% | $3.25 | 0 | 1 | |
| Hughes Thomas E. | See Remarks | 125247 0.1963% | $3.25 | 2 | 4 | +20.01% |
| Celano Michael | Chief Financial Officer | 112746 0.1767% | $3.25 | 2 | 0 | +15.27% |
| Goldberg Avi Y. | director | 53734 0.0842% | $3.25 | 0 | 3 | |
| Heller Frances K | director | 47961 0.0752% | $3.25 | 4 | 0 | +29.04% |
| KIM DENNIS D | Chief Medical Officer | 21443 0.0336% | $3.25 | 3 | 3 | +11.81% |
| Allen Patricia L | Chief Financial Officer | 19793 0.031% | $3.25 | 2 | 0 | +14.98% |
| Shankar Gopi | Chief Development Officer | 5000 0.0078% | $3.25 | 1 | 0 | |
| Truitt Joseph | director | 2750 0.0043% | $3.25 | 1 | 0 | +8.67% |
| Secor Alicia | Chief Commercial Officer | 0 0% | $3.25 | 1 | 1 | +21.04% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Deerfield Management | $161.15M | 33.28 | 21.23M | +25.33% | +$32.57M | 0.39 | |
| RA Capital Management, L.P. | $45.88M | 9.48 | 6.05M | New | +$45.88M | 0.05 | |
| Janus Henderson | $30.46M | 6.3 | 4.02M | +52.25% | +$10.45M | 0.02 | |
| Blue Owl Capital Holdings Lp | $30.32M | 6.26 | 3.99M | +16.99% | +$4.4M | 2.54 | |
| Goldman Sachs | $25.94M | 5.36 | 3.42M | +2,452.98% | +$24.92M | 0.01 | |
| The Vanguard Group | $17.97M | 3.71 | 2.37M | +62.7% | +$6.93M | <0.0001 | |
| BlackRock | $17.75M | 3.67 | 2.34M | +40.22% | +$5.09M | <0.0001 | |
| Verition Fund Management Llc | $11.4M | 2.35 | 1.5M | -46.58% | -$9.94M | 0.11 | |
| Adage Capital Partners Gp L L C | $10.88M | 2.25 | 1.43M | +12.28% | +$1.19M | 0.02 | |
| Citadel Advisors LLC | $8.84M | 1.83 | 1.16M | +70.62% | +$3.66M | 0.01 | |
| Woodline Partners LP | $8.73M | 1.8 | 1.15M | +44.47% | +$2.69M | 0.07 | |
| Driehaus Capital Management LLC | $8.26M | 1.71 | 1.09M | New | +$8.26M | 0.08 | |
| Alger | $7.5M | 1.55 | 987,933 | +1,041.31% | +$6.84M | 0.04 | |
| Geode Capital Management | $6.6M | 1.36 | 869,383 | +34.22% | +$1.68M | <0.01 | |
| Mangrove Partners | $6.5M | 1.34 | 855,815 | +6.21% | +$379,500.01 | 0.07 | |
| Millennium Management LLC | $5.94M | 1.23 | 782,270 | New | +$5.94M | <0.01 | |
| Altium Capital Management Lp | $5.28M | 1.09 | 695,000 | New | +$5.28M | 0.62 | |
| DAFNA Capital Management, LLC | $4.98M | 1.03 | 656,373 | +102.66% | +$2.52M | 0.12 | |
| RTW Investments, LP | $4.93M | 1.02 | 650,000 | New | +$4.93M | 0.07 | |
| Assenagon Asset Management S.A. | $4.83M | 1 | 636,185 | New | +$4.83M | 0.01 | |
| State Street | $4.79M | 0.99 | 630,680 | +35.6% | +$1.26M | <0.0001 | |
| Alyeska Investment Group L P | $4.17M | 0.86 | 550,027 | New | +$4.17M | 0.03 | |
| Renaissance Technologies | $3.82M | 0.79 | 503,442 | +103.79% | +$1.95M | 0.01 | |
| Ikarian Capital LLC | $3.33M | 0.69 | 438,528 | -27.26% | -$1.25M | 0.46 | |
| Point72 Asset Management | $3.33M | 0.69 | 438,400 | -2.66% | -$91,080.00 | 0.01 | |
| Northern Trust | $2.24M | 0.46 | 295,422 | +10.11% | +$205,916.61 | <0.0001 | |
| Deutsche Bank | $2.06M | 0.43 | 271,924 | -0.17% | -$3,407.91 | <0.01 | |
| Atlas Venture Advisors Inc | $1.76M | 0.36 | 232,184 | -20.54% | -$455,400.11 | 0.35 | |
| Two Sigma | $1.6M | 0.33 | 210,472 | +518.51% | +$1.34M | <0.01 | |
| GHOST TREE CAPITAL LLC | $1.6M | 0.33 | 210,603 | New | +$1.6M | 0.02 | |
| Ubs Oconnor Llc | $1.54M | 0.32 | 202,783 | -36.61% | -$888,925.64 | 0.07 | |
| Two Sigma Advisers LP | $1.47M | 0.3 | 193,424 | +76.93% | +$638,318.93 | <0.01 | |
| Dimensional Fund Advisors | $1.33M | 0.28 | 175,744 | -9.96% | -$147,579.96 | <0.0001 | |
| Opaleye Management Inc | $1.32M | 0.27 | 174,413 | -72.03% | -$3.41M | 0.29 | |
| Caption Management Llc | $1.08M | 0.22 | 142,900 | New | +$1.08M | 0.03 | |
| Voya Investment Management LLC | $999,694.00 | 0.21 | 131,712 | +1,048.02% | +$912,613.94 | <0.01 | |
| Concentric Capital Strategies Lp | $936,037.00 | 0.19 | 123,325 | New | +$936,037.00 | 0.06 | |
| JPMorgan Chase | $902,352.00 | 0.19 | 118,887 | +96.5% | +$443,141.99 | <0.0001 | |
| Nuveen | $806,286.00 | 0.17 | 106,230 | +175.98% | +$514,131.61 | <0.0001 | |
| Boothbay Fund Management LLC | $780,965.00 | 0.16 | 102,894 | -20.82% | -$205,415.64 | 0.03 | |
| Marshall Wace | $757,391.00 | 0.16 | 99,788 | New | +$757,391.00 | <0.01 | |
| Hap Trading Llc | $751,289.00 | 0.16 | 98,984 | New | +$751,289.00 | 0.23 | |
| Qube Research & Technologies | $676,224.00 | 0.14 | 89,094 | New | +$676,224.00 | <0.01 | |
| BNY Mellon | $651,033.00 | 0.13 | 85,775 | -11.36% | -$83,406.61 | <0.0001 | |
| Bridgeway Capital Management | $641,355.00 | 0.13 | 84,500 | -29.29% | -$265,650.00 | 0.01 | |
| Charles Schwab | $630,038.00 | 0.13 | 83,009 | +12.54% | +$70,177.10 | <0.0001 | |
| Schonfeld Group | $614,031.00 | 0.13 | 80,900 | New | +$614,031.00 | <0.01 | |
| Jump Financial Llc | $593,576.00 | 0.12 | 78,205 | New | +$593,576.00 | 0.01 | |
| Simplex Trading Llc | $462,000.00 | 0.1 | 60,900 | New | +$462,000.00 | 0.01 | |
| Artia Global Partners Lp | $441,662.00 | 0.09 | 58,190 | New | +$441,662.00 | 0.11 |
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.